Food Allergy Center: Research

As a result of its close affiliation with UT Southwestern Medical Center at Dallas, Children’s Food Allergy Center is home to groundbreaking basic science and clinical research in food allergy.

Clinical Trials

Peanut Patch Study

IRB # 022012-080: A Double-Blind, Placebo-Controlled, Randomized Trial to Study VIASKIN® Peanut's Efficacy and Safety For Treating Peanut Allergy in Children and Adults  (VIPES) 

  •  Viaskin® Peanut is a medication using a specially designed patch applied to the skin that contains a dry extract of peanut protein. The goal is to desensitize a peanut-allergic person to peanuts by repeated exposures to small amounts of peanut proteins contained in the patch in order to build desensitization to peanuts over time.

  •  Must be between the ages of 6 and 18 with a peanut allergy

  •  Enrolling NOW!

  • Contact Amy Arneson at 214-456-1438 or amy.arneson@childrens.com for more information

Oral Immunotherapy

112009-006: Dendritic Cell Responses to Viral Stimulation in Peanut Allergic Subjects Undergoing Peanut Oral Immunotherapy

  • Oral immunotherapy is an experimental treatment for food allergies. Small, escalating, amounts of peanut flour are fed to   peanut allergic patients to increase their tolerance.

  •  Must be between the ages of 3-16 with a peanut allergy to participate in this study.

  •   Enrollment currently on hold

102011-052:  Walnut Oral Immunotherapy for Tree Nut Allergy

  • Oral immunotherapy is an experimental treatment for food allergies. Small, escalating, amounts of walnut Flour or placebo are fed to patients with walnut and one other tree nut allergy, to increase their tolerance.

  • Must be between the ages of 6-45 with a walnut and one other qualifying tree nut to participate in this study.

  •  Enrollment beginning soon.

Chinese Herbal Therapy (FAHF-2)

012012-187: Effect of Chinese Herbal Medicine on Food Allergy

  • Food Allergy Herbal Formula-2 (FAHF-2) derived from a traditional chinese medicine formula. This Phase II trial will determine the effectiveness of FAHF-2 when used as a treatment for food allergy.

  • Must be between the ages of 12-45 years old and have a food allergy to peanut, tree nut, sesame, fish, or shellfish to participate in this study.

  • Enrollment beginning soon.

 

For complete inclusion/exclusion criteria on open clinical trials: 

Amy Arneson, RN, BSN
Clinical Research Coordinator
214-456-1438
amy.arneson@childrens.com
http://clinicaltrials.gov/

Contact the Food Allergy Center

214-456-2084